Prot# 004-01: A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of MK-7009 in Hepatitis C Infected Patients

Project: Research project

Project Details

StatusFinished
Effective start/end date10/8/0710/8/10

Funding

  • Merck & Co., Inc. (004-01)